|
|
Volumn 433, Issue 7026, 2005, Pages 561-
|
|
Gene therapy put on hold as third child develops cancer
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
BONE MARROW TRANSPLANTATION;
CANCER RISK;
CARCINOGENICITY;
CLINICAL RESEARCH;
CLINICAL TRIAL;
COMBINED IMMUNODEFICIENCY;
DRUG SAFETY;
GENE THERAPY;
GENE VECTOR;
HUMAN;
NOTE;
OUTCOMES RESEARCH;
PRIORITY JOURNAL;
RISK ASSESSMENT;
X CHROMOSOME LINKED DISORDER;
ARTICLE;
CHILD;
GENETICS;
LEGAL ASPECT;
NEOPLASM;
CHILD;
CLINICAL TRIALS;
GENE THERAPY;
HUMANS;
NEOPLASMS;
SEVERE COMBINED IMMUNODEFICIENCY;
|
|
EID: 14144253164
PISSN: 00280836
EISSN: None
Source Type: Journal
DOI: 10.1038/433561a Document Type: Note |
|
Times cited : (129)
|
|
References (0)
|